Christopher G. Earnhart

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Development and optimization of OspC chimeritope vaccinogens for Lyme disease”.

Development and optimization of OspC chimeritope vaccinogens for Lyme disease

Vaccine(2020)10.1016/j.vaccine.2020.01.027

N/A

0DataRank · unranked

43 citations

Nathaniel S. O’Bier, Lee D. Oliver, Andrew C. Camire, Christopher G. Earnhart, DeLacy V. L. Rhodes +5 more

A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques

Med(2022)10.1016/j.medj.2022.01.004

N/A

0DataRank · unranked

22 citations

Joseph P. Nkolola, Pavlo Gilchuk, Abishek Chandrashekar, Jingyou Yu, Robert V. House +21 more

Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariants

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.21.513237

N/A

0DataRank · unranked

5 citations

Kathryn T. Arrildt, Adam Zemła, Edmond Y. Lau, Fangqiang Zhu, Dante P. Ricci +38 more

Computationally restoring the potency of a clinical antibody against Omicron

Nature(2024)10.1038/s41586-024-07385-1

N/A

0DataRank · unranked

49 citations

Kathryn T. Arrildt, Adam Zemła, Edmond Y. Lau, Fangqiang Zhu, Dante P. Ricci +71 more